Source - RNS
RNS Number : 7595M
GlaxoSmithKline PLC
17 October 2016
 

GlaxoSmithKline plc (the 'Company')

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr M M Slaoui

b)

Position/status

Chairman, Global Vaccines

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

 

 

b)

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's US Deferred Performance Plan.

c)

Price(s) and

volume(s)

Price(s)

Volume(s)

$46.1526

244.955

 

 

 

d)

Aggregated information

 

Aggregated volume Price

n/a (single transaction)

 

 

 

 

 

 

e)

Date of the transaction

2016-10-13

f)

Place of the transaction

 

New York Stock Exchange (XNYS)

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr D E Troy

b)

Position/status

SVP & General Counsel

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

  

 

 

b)

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's US Deferred Performance Share Plan.

c)

Price(s) and

volume(s)

Price(s)

Volume(s)

$46.1526

324.557

$46.1526

5.002

 

 

 

d)

Aggregated information

 

Aggregated volume Price

 

 

 

 

329.559

$46.1526

e)

Date of the transaction

2016-10-13

f)

Place of the transaction

 

New York Stock Exchange (XNYS)

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDDLFFQBFZFBB

Related Charts

GlaxoSmithKline (GSK)

-1.50p (-0.10%)
delayed 18:15PM